Moderna submits authorisation application for coronavirus vaccine Spikevax XBB.1.5


13 July  2023 - Swissmedic examining application for vaccine against Omicron subvariant XBB.1.5

Moderna Switzerland has submitted an application to Swissmedic, the Swiss Agency for Therapeutic Products, for authorisation of its updated monovalent COVID-19 vaccine.

Read Swissmedic News

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Vaccine , Dossier , Switzerland